Literature DB >> 19490383

Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern?

Nikolaos Dagres1, Gerhard Hindricks, Hans Kottkamp, Philipp Sommer, Thomas Gaspar, Kerstin Bode, Arash Arya, Daniela Husser, Loukianos S Rallidis, Dimitrios Th Kremastinos, Christopher Piorkowski.   

Abstract

INTRODUCTION: Catheter ablation is potentially curative treatment for atrial fibrillation (AF). However, complications are more frequent and more severe compared with other ablation procedures. We investigated the complication rate in 1,000 AF ablation procedures in a high-volume center and examined possible risk factors. METHODS AND
RESULTS: One thousand consecutive circumferential pulmonary vein radiofrequency ablations were performed for symptomatic, drug-refractory AF. Major complications were defined as the ones that were life threatening, caused permanent harm, and required intervention or prolonged hospitalization. Thirty-nine (3.9%) major periprocedural complications were observed. There was no death immediately associated with the procedure. However, there were 2 deaths (0.2%) of unclear cause, 14 days and 4 weeks after ablation. The most common complications were tamponade (1.3%), treated mainly by percutaneous drainage, and vascular complications (1.1%). There were also 4 thromboembolic events (0.4%): 3 nonfatal strokes and one transient ischemic attack. Importantly, 2 cases (0.2%) of atrial-esophageal fistula and 2 cases (0.2%) of endocarditis were observed. Factors associated with an increased complication risk were age > or = 75 years (hazard ratio 3.977, P = 0.022) and congestive heart failure (hazard ratio 5.174, P = 0.001).
CONCLUSION: AF ablation still has a considerable number of major complications that may be life threatening or may lead to severe residues. Atrial-esophageal fistula is still observed despite continuous systematic methods to prevent it. Stroke, tamponade, and vascular complications are the most frequent major complications. However, in most patients treatment can be conservative and results in complete recovery. Advanced age and congestive heart failure seem to be associated with an increased risk of complications.

Entities:  

Mesh:

Year:  2009        PMID: 19490383     DOI: 10.1111/j.1540-8167.2009.01493.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  61 in total

1.  Measuring luminal esophageal temperature during pulmonary vein isolation of atrial fibrillation.

Authors:  Daisuke Sato; Kunihiro Teramoto; Hiroki Kitajima; Naoto Nishina; Yoshitomi Kida; Hiroki Mani; Masahiro Esato; Yeong-Hwa Chun; Toshiji Iwasaka
Journal:  World J Cardiol       Date:  2012-05-26

2.  Cardiac tamponade following pericarditis 18 days after catheter ablation of atrial fibrillation.

Authors:  T Lambert; C Steinwender; F Leisch; R Hofmann
Journal:  Clin Res Cardiol       Date:  2010-05-09       Impact factor: 5.460

3.  Non-fluoroscopic catheter visualization using MediGuide™ technology: experience from the first 600 procedures.

Authors:  P Sommer; S Richter; G Hindricks; S Rolf
Journal:  J Interv Card Electrophysiol       Date:  2014-01-16       Impact factor: 1.900

4.  Esophageal-left atrial fistula: an unsual cause.

Authors:  Bhavesh Meel; Prakash Chandwani; Ravinder Singh Rao; Sudhir Kumar Vyas
Journal:  Indian Heart J       Date:  2014 Mar-Apr

5.  Delayed cardiac tamponade 8 months after pulmonary vein isolation.

Authors:  Tetsuo Yamanaka; Toru Fukatsu; Tatsuya Kamon; Satoshi Kitahara; Yoshimaro Ichinohe; Hirotaka Komatsu; Yasunobu Hirata
Journal:  J Cardiol Cases       Date:  2017-05-05

Review 6.  Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials.

Authors:  Chen Chen; Xinbin Zhou; Min Zhu; Shenjie Chen; Jie Chen; Hongwen Cai; Jin Dai; Xiaoming Xu; Wei Mao
Journal:  J Interv Card Electrophysiol       Date:  2018-03-16       Impact factor: 1.900

7.  Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-a single-center experience.

Authors:  Christopher Ruslan Hayes; David Keane
Journal:  J Interv Card Electrophysiol       Date:  2010-03       Impact factor: 1.900

8.  A rare complication following radiofrequency ablation.

Authors:  Ramyah Rajakulasingam; Rohin Francis; Azad Ghuran
Journal:  BMJ Case Rep       Date:  2013-02-18

9.  A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial Fibrillation.

Authors:  Ping Xia; Rupesh Kotecha; Naveen Sharma; Martin Andrews; Kevin L Stephans; Carlos Oberti; Sara Lin; Oussama Wazni; Patrick Tchou; Walid I Saliba; John Suh
Journal:  Cureus       Date:  2016-07-11

10.  Stroke risk associated with balloon based catheter ablation for atrial fibrillation: Rationale and design of the MACPAF Study.

Authors:  Karl Georg Haeusler; Lydia Koch; Juliane Ueberreiter; Matthias Endres; Heinz-Peter Schultheiss; Peter U Heuschmann; Alexander Schirdewan; Jochen B Fiebach
Journal:  BMC Neurol       Date:  2010-07-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.